Given that GLP-1 receptor agonists produce significant weight reduction typically 515% of body weight in clinical trials, with results varying by medication, dosage and individual responsethere is theoretical interest in whether these medications might indirectly improve vasomotor symptoms through weight loss
Libido and sexual function typically improve as well
Best For Weight loss and appetite control Method Subcutaneous injection Frequency Weekly, provider-directed Eligibility for HSA or FSA reimbursement depends on your individual plan and medical necessity
This enzyme degrades GSH (reduced glutathione), weakening the body
For people with obesity plus metabolic dysfunction, GLP-1s look like one of the most powerful risk-reduction tools we have
Quarato G, Mari L, Barrows NJ, Yang M, Ruehl S, Chen MJ, et al